Payer mix and reimbursement exposure
How revenue splits across Medicare, Medicaid, commercial payers and cash, and how sensitive it is to fee-schedule or contract changes.
Medical Supply & DME
Selling a medical supply or DME company? Get ahead of the buyer.
Buyers will dig into your payer mix, accreditation, referral sources and how much still runs through you. Find the problems before they do. Omega1 Group gets DME, home medical, med-surg, respiratory, O&P and mobility owners in the USA and Canada exit-ready, then runs a confidential, competitive sale.
How do I sell my DME or medical supply company?
Start 12 to 24 months before you want to close. Tighten the areas buyers diligence hardest (payer mix, accreditation and audit history, referral-source concentration, billing and documentation, and owner dependence), then approach qualified buyers confidentially under NDA with clean financials and a clear story. An advisor runs the process so you can keep running the company.
Who we work with
- DME / HME suppliers
- Med-surg distributors
- Respiratory and oxygen
- Orthotics & prosthetics
- Mobility and rehab
- Diabetic, ostomy and urological supplies
- Home infusion suppliers
Value drivers
What buyers will scrutinize in your medical supply company
Every gap here is leverage for the buyer. We help you close them before you go to market.
Accreditation and compliance history
Current accreditation for every location and product category, clean audit outcomes, and documentation that holds up when a buyer's team samples files.
Referral-source concentration
Whether orders come from a broad base of physicians, hospitals and facilities or depend on a few relationships the owner personally holds.
Recurring and rental revenue
Resupply programs and rental streams that renew without new selling effort tend to be valued more favorably than one-time sales.
Billing, intake and documentation systems
A billing operation and intake process that a buyer can see, measure and keep running after the owner steps back.
Owner dependence
Who manages payers, key referral sources and the team day to day, and whether that knowledge is written down.
Find out where a buyer would push back.
Get your Exit-Readiness Score in four minutes.
Buyer types
Who buys medical supply companies
Strategic acquirers
Larger regional or national suppliers adding territory, product lines or payer contracts.
Private equity-backed platforms
Investor-backed groups building scale through acquisitions in home medical and supply categories.
Independent sponsors and individual operators
Experienced operators or small investor groups buying a single well-run company.
Management or family succession
An internal team or next-generation owner, often with outside financing.
Omega1 Group leverages a private M&A network in which family offices, investors, private equity firms and business owners participate. For medical supply and DME owners, we leverage that network alongside targeted outreach to strategic acquirers in the sector, so you can weigh buyers who understand reimbursement and referral-driven businesses.
Different buyers pay for different things. A competitive process puts them side by side so you can compare price, terms, your role and your team, instead of taking the first offer.
Don't negotiate with one buyer. Run a process.
USA & Canada
Selling in the US vs. Canada
United States
In the US, Medicare enrollment, accreditation and surety-bond requirements, state licensing and payer contracts all transfer differently depending on deal structure. CMS has published the timeline for Round 2028 of the DMEPOS Competitive Bidding Program, so buyers will ask how your product categories and markets are exposed. Plan these questions with your healthcare attorney early.
Canada
In Canada, funding programs and supplier rules are provincial. For example, Ontario's Assistive Devices Program has its own vendor registration. Buyers will look at program approvals, contracts with health authorities and private-insurer relationships province by province. We work in English-language engagements and coordinate with your Canadian accountant and lawyer.
This is general information, not legal or tax advice. We coordinate with your attorney and accountant on regulatory and structuring questions.
How it works
Our process for medical supply owners
- Get your scoreFour minutes. See where a buyer would discount your business today.
- Exit callA confidential 15-minute call: your goals, your timeline, your options. Straight answers.
- Readiness reviewWe find what a buyer's diligence would find: owner dependence, team, reporting and revenue quality.
- Build valueClose the gaps before a buyer can use them against you: systems, team and recurring revenue.
- Go to marketWe run a confidential, competitive process under NDA, leveraging a private M&A network and targeted outreach, and fight for your number.
Free · 4 minutes · Confidential
Get your Exit-Readiness Score
Ten questions. Get your score, your tier and what it means for your exit, before a buyer's diligence tells you.
- Market ready
- Close a few gaps
- Build value first
Insights
Related guides
Medical Supply & DME
Exit-readiness checklist for medical supply and DME distributors
An exit-readiness checklist for DME and medical supply owners: reimbursement, accreditation, referral sources, billing, team and the CMS Round 2028 timeline.
Exit readinessHow owner dependence affects business value and deal terms
Why buyers pay less, or ask for earn-outs, when a business runs through its owner, and a practical plan to reduce owner dependence before you sell.
FAQ
Questions owners ask
How long does it take to sell a DME company?
Preparation usually matters more than the sale itself. Many owners spend months tightening financials, documentation and team structure before going to market, and the sale process then runs through buyer outreach, offers, diligence and closing. We give you a realistic timeline after reviewing your business.
Will my referral sources or staff find out I'm thinking about selling?
Not from us. Your business is never publicly listed, buyers sign an NDA before receiving details, and we agree with you up front on when and how key people are told.
Does competitive bidding affect the value of my company?
It can. Buyers will ask which of your product categories and markets are exposed to the Round 2028 DMEPOS Competitive Bidding Program and how you plan to respond. Having a clear answer, backed by your payer data, reduces uncertainty in diligence.
Do I need audited financial statements to sell?
Not always, but you do need clean, consistent financials that tie to tax returns and billing data. Many owners start with a quality-of-earnings style review so there are no surprises when a buyer's accountants look.
Do you buy medical supply companies?
No. Omega1 Group is an advisor that works for the owner. We do not buy companies or make purchase offers.
Do you work with suppliers in Canada?
Yes. We work with owners across the USA and Canada in English-language engagements and coordinate with your provincial advisors on program, tax and legal questions.
Your exit. Your number.
Every month you wait is a month you could spend building value. Book a confidential 15-minute exit call and get a straight read on where you stand.